OBJECTIVE: To provide an up-to-date review of current guidelines, previous trials, and new
trials regarding aspirin use in primary prevention of cardiovascular (CV) disease in the …

OBJECTIVE: This article aims to use the available evidence assessing aspirin for primary
prevention of cardiovascular (CV) events in the elderly to determine its appropriate use …

In the treatment or secondary prevention of cardiovascular disease (CVD), there is general
consensus that the absolute benefits of aspirin far outweigh the absolute risks. Despite …

Aspirin (acetylsalicylic acid), the most widely used antiplatelet drug, is clinically effective for
the prevention of vascular ischaemic events. Very few primary or secondary prevention trials …

While the use of aspirin for the secondary prevention of cardiovascular (CV) disease is
undisputed, 1 the decision to use aspirin for primary CV disease prevention is largely based …

The role of aspirin in the secondary prevention of occlusive cardiovascular events has now
been well established. Given this, aspirin in primary prevention has been the focus of …

Aims The efficacy and safety of aspirin for primary cardiovascular disease (CVD) prevention
is controversial. The aim of this study was to investigate the efficacy and safety of aspirin in …

Aspirin is one of the most often used drugs for prevention and treatment of a variety of
thrombotic disorders. This narrative review aims to provide an overview of evidence …

Recent trials suggest that aspirin for primary prevention may do more harm than good for
some, including adults over 70 years of age. We sought to assess how primary care …

Background: Cardiovascular disease (CVD) is the leading cause of death in the United
States. Purpose: To update a systematic review about the benefits of aspirin for the primary …